Want to join the conversation?
In 2015, $MCO's MIS segment revenue grew 3% versus 2014, helped by benefits from changes in the mix of fee type and new fee initiatives. MA revenue grew 8% versus 2014, reflecting growth in ERS and RD&A. Excluding impact from unfavorable changes in FX rates, MIS revenue grew 8% and MA revenue grew 12%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.